In our December issue of Pharmaceutical Executive
FEATURES
Cover Story
CEO Snapshot: Steve Collis, Four Years Forward
William Looney
Pharm Exec first began tracking changes in the drug distribution world back in 2011, when we featured a conversation with the sector's newest CEO at the time, Steve Collis of AmerisourceBergen. Four years later, we meet up again with Collis for a wide-ranging talk on what customers want, successful M&As, and what he sees as his key achievements |
From the Editor
Twisting the Spigot: Demographic of Distress
William Looney
A new discipline—population health—contests disease treatment as an end in itself. It asks: besides advancing the science of medicine, what do biopharmaceuticals actually do to improve health overall? |
Value
Defining Value: The Payer Perspective
Susan Abedi
Can we do a better job of understanding other stakeholders' definitions of value to prepare us for smoother engagements? And particularly in the US, where the debate is moving more and more quickly as healthcare costs escalate, can we use a broader understanding of stakeholders’ definitions to support new commercial engagement approaches? The answer is Yes. |
Emerging Markets
Colombia: Portage to Latin America
Casey McDonald
As an entry port to Latin America from North America, Europe, or Asia, Colombia's geographical positioning makes clear sense for accessing a region that seems remote and exotic. Casey McDonald visits with industry and regulatory officials in Bogotá to discuss Colombia's strategy for growing its life sciences enterprise. |
Forecast
Pharma and Biotech Financial Forecast: Mostly Sunny
Casey McDonald
The pharma and biotech business is coming off a strong year but headwinds persist—a clear product strategy, focused around a more demanding customer base, is the best way to ensure smooth sailing in 2016.
|
 |
ALSO IN THIS ISSUE
Marketing Curative Therapies: Are We Ready?
Eric M. Bachman
The eight trends brought on by “once-and-done” interventions that may transform thinking around healthcare marketing.
Drug Pricing in Europe: A Discordant Bandwagon
Reflector
The Council of Europe is the latest group to jump into the drug-pricing debate blazing its way through continent.
Pharma Caught in the Political Crosshairs
Jill Wechsler
Drug pricing backlash threatens regulatory reform, R&D advances.
Best Breakthroughs: Top Medical Innovations for 2016
Casey McDonald
The Cleveland Clinic's 2016 Medical Innovation Summit capped its yearly event with a Late Show-style Top 10 list bolstering "Amazing Science.
|
|
| |
| WEBCASTS |
| New Tufts CSDD Research: Industry Adoption of eClinical Solutions and CDISC Standards
|
| The Growing Aging Consumer Population – Living Longer, Living Smarter |
Engineer Your Business to Win in the Mobile Selling Moment
|
| |
